According to IMARC Group’s latest report, titled “Parkinson's Disease Treatment Market Share, Trends, Size, Growth, Opportunity and Forecast 2020-2025”, the global parkinson's disease treatment market grew at a CAGR of around 6% during 2014-2019. Looking forward, IMARC Group expects the global market to continue its moderate growth during 2020-2025.
The parkinson's disease treatment market is primarily driven by the steadily increasing number of patients suffering from Parkinson’s disease on the global level. Along with this, a considerable rise in the geriatric population that is more prone to develop neurodegenerative ailments is expected to provide a thrust to the market growth. Moreover, continual developments in gene therapy, neurostimulation tools, and neural transplantation procedures are anticipated to create a positive outlook for the market. Some of the other factors contributing to the market growth include rising awareness regarding efficient treatment options and significant improvements in the healthcare infrastructure.
Parkinson’s disease refers to a progressive nervous system disorder that affects movements in an individual. It is characterized by the degeneration of motor neurons in the brain that leads to the development of rigidity, tremors, motor impairment, depression and dementia. Healthcare professionals are widely utilizing medications, supportive therapies and surgical procedures to manage the symptoms of the disease in an efficient manner and offer comfort to the patient during a seizure. Some of the most commonly prescribed medications include dopamine agonists, anticholinergics and carbidopa-levodopa medicines.
Get a PDF sample of this report for more detailed market insights: https://www.imarcgroup.com/parkinsons-disease-treatment-market/requestsa...
Parkinson's Disease Treatment Market 2020-2025 Competitive Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the parkinson's disease treatment market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
• AbbVie Inc.
• Acadia Pharmaceuticals Inc.
• Boehringer Ingelheim International GmbH (C. H. Boehringer Sohn AG & Co. KG)
• F. Hoffmann-La Roche AG
• GlaxoSmithKline Plc
• H. Lundbeck A/S
• Merck & Co. Inc.
• Mylan N.V.
• Novartis AG
• Orion Corporation
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries
• Wockhardt Ltd.
The report has segmented the global parkinson's disease treatment market on the basis of region, drug class, administration and distribution channel.
Breakup by Drug Class:
• Carbidopa/Levodopa
• Dopamine Receptor Agonists
• MAO Inhibitors
• COMT Inhibitors
• Anticholinergics
• Others
Breakup by Route of Administration:
• Oral
• Transdermal
• Subcutaneous
• Intestinal Infusion
• Others
Breakup by Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Breakup by Region:
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa
Explore full report with table of contents: https://www.imarcgroup.com/parkinsons-disease-treatment-market
Key highlights of the report:
• Market Performance (2014-2019)
• Market Outlook (2020- 2025)
• Market Trends
• Market Drivers and Success Factors
• The Impact of COVID-19 on the Global Market
• Value Chain Analysis
• Structure of the Global Market
• Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Browse Related Reports:
Polycystic Ovarian Syndrome Treatment Market Outlook
Hypoactive Sexual Desire Disorder Treatment Market Outlook
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
USA: +1-631-791-1145
Follow us on twitter: @imarcglobal